Eicosapentaenoic Acid/Metformin

二十碳五烯酸/二甲双胍

Report date: 2022/02/18 15:11:37

Base Information

Drug NameEicosapentaenoic Acid/Metformin
Drug Alias Name二甲双胍+二十碳五烯酸Eicosapentaenoate/metformin二甲双胍/二十碳五烯酸Metformin/eicosapentaenoateMetformin/eicosapentaenoic acid +[7] 
ClassificationSmall molecules
Mechanisms of ActionThromboxane A2 synthase inhibitorsProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsThromboxane A2 synthaseProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsHypertriglyceridemiaDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThetis Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThetis Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsHypertriglyceridemiaDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A